mk2 Biotechnologies - Renewable Carbon News

Renewable Carbon News
mk2 Biotechnologies

6 July 20221 July 2022

mk2 Biotechnologies, WACKER and TUM jointly develop a process for the large-scale production of antimicrobial peptides based on sustainable fermentation

The project particularly targets the development of new, highly potent AMPs, the development of a planetary circulating solid-liquid reactor, and the integration of both technologies into large-scale bio-production facilities

mk2 Biotechnologies, WACKER und TUM entwickeln gemeinsam Verfahren zur großtechnischen Produktion von anti-mikrobiellen Peptiden auf Basis nachhaltiger Fermentation

Ziele des Projekts sind die Entwicklung neuer hochwirksamer AMPs, die Entwicklung eines planetar-zirkulierenden Fest-Flüssig-Reaktors sowie die Integration beider Technologien in großtechnische Bioproduktionsanlagen

10 August 20215 August 2021

mk2 Biotechnologies Receives a Multi-Million Sum in Seed Funding

Company thrives to accomplish additional development milestones towards industrializing its novel peptide production platform